These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 26077897)

  • 1. Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study.
    Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yamanaka S; Iiyama T; Kumagai N; Furuno T; Sugiura T; Kitaoka H
    BMC Cardiovasc Disord; 2015 Jun; 15():53. PubMed ID: 26077897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Jenab Y; Pourjafari M; Darabi F; Boroumand MA; Zoroufian A; Jalali A
    J Cardiol; 2014 Feb; 63(2):140-4. PubMed ID: 24011925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
    J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.
    Zhang L; Zhou X; Wang J; Mu Y; Liu B; Lv W; Wang Y; Liu H; Liu H; Zhi G
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):499-507. PubMed ID: 27878699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endomyocardial radial strain imaging and left ventricular relaxation abnormalities in patients with hypertrophic cardiomyopathy or hypertensive left ventricular hypertrophy.
    Minoshima M; Noda A; Nishizawa T; Hara Y; Sugiura M; Iino S; Nagata K; Koike Y; Murohara T
    Circ J; 2009 Dec; 73(12):2294-9. PubMed ID: 19838000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
    Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
    Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitive cardiac troponin T: a biomarker of left-ventricular diastolic dysfunction in hemodialysis patients.
    Sun L; Ji Y; Wang Y; Ding M; Xie X; Zhu D; Chen F; Zhang N; Wang X
    J Nephrol; 2018 Dec; 31(6):967-973. PubMed ID: 30350298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.
    Takashio S; Yamamuro M; Izumiya Y; Hirakawa K; Marume K; Yamamoto M; Ueda M; Yamashita T; Ishibashi-Ueda H; Yasuda S; Ogawa H; Ando Y; Anzai T; Tsujita K
    ESC Heart Fail; 2018 Feb; 5(1):27-35. PubMed ID: 28869340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between high-sensitivity troponin T, left ventricular hypertrophy, and myocardial performance index.
    Kaypakli O; Gür M; Gözükara MY; Uçar H; Kivrak A; Şeker T; Şahin DY; Elbasan Z; Türkoğlu C; Çayli M
    Herz; 2015 Nov; 40(7):1004-10. PubMed ID: 26087700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy.
    Gommans DF; Cramer GE; Bakker J; Michels M; Dieker HJ; Timmermans J; Fouraux MA; Marcelis CL; Verheugt FW; Brouwer MA; Kofflard MJ
    Heart; 2017 Feb; 103(4):293-299. PubMed ID: 27506680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk.
    Cramer G; Bakker J; Gommans F; Brouwer M; Kurvers M; Fouraux M; Verheugt F; Kofflard M
    Am J Cardiol; 2014 Apr; 113(7):1240-5. PubMed ID: 24513467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease.
    Hayashi S; Yamada H; Nishio S; Hotchi J; Bando M; Takagawa Y; Saijo Y; Hirata Y; Sata M
    J Cardiol; 2015 Jun; 65(6):519-25. PubMed ID: 25199979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Echocardiographic tissue Doppler imaging analysis of the systolic and early diastolic velocities of the mitral annulus motion in hypertrophic cardiomyopathy and in top-level athletes].
    Butz T; van Buuren F; Mellwig KP; Langer C; Oldenburg O; Treusch KA; Meissner A; Plehn G; Trappe HJ; Horstkotte D; Faber L
    Ultraschall Med; 2012 Oct; 33(5):455-62. PubMed ID: 21294072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of Fabry cardiomyopathy by tissue Doppler imaging.
    Pieroni M; Chimenti C; Ricci R; Sale P; Russo MA; Frustaci A
    Circulation; 2003 Apr; 107(15):1978-84. PubMed ID: 12668521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall.
    Oki T; Tanaka H; Yamada H; Tabata T; Oishi Y; Ishimoto T; Nagase N; Shinohara H; Sakabe K; Fukuda N
    Am J Cardiol; 2004 Apr; 93(7):864-9. PubMed ID: 15050490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy.
    Kaski JP; Tomé-Esteban MT; Mead-Regan S; Pantazis A; Marek J; Deanfield JE; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1307-11. PubMed ID: 18070943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.